Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Lipid profiles of prostate cancer cells.

Sorvina A, Bader CA, Caporale C, Carter EA, Johnson IRD, Parkinson-Lawrence EJ, Simpson PV, Wright PJ, Stagni S, Lay PA, Massi M, Brooks DA, Plush SE.

Oncotarget. 2018 Oct 30;9(85):35541-35552. doi: 10.18632/oncotarget.26222. eCollection 2018 Oct 30.

2.

Endosomal gene expression: a new indicator for prostate cancer patient prognosis?

Johnson IR, Parkinson-Lawrence EJ, Keegan H, Spillane CD, Barry-O'Crowley J, Watson WR, Selemidis S, Butler LM, O'Leary JJ, Brooks DA.

Oncotarget. 2015 Nov 10;6(35):37919-29. doi: 10.18632/oncotarget.6114.

3.

Altered endosome biogenesis in prostate cancer has biomarker potential.

Johnson IR, Parkinson-Lawrence EJ, Shandala T, Weigert R, Butler LM, Brooks DA.

Mol Cancer Res. 2014 Dec;12(12):1851-62. doi: 10.1158/1541-7786.MCR-14-0074. Epub 2014 Jul 30.

4.

Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.

Johnson IR, Parkinson-Lawrence EJ, Butler LM, Brooks DA.

Prostate. 2014 May;74(5):547-60. doi: 10.1002/pros.22777. Epub 2014 Jan 16.

PMID:
24435746
5.

Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured Cells.

Kamei M, Kasperski K, Fuller M, Parkinson-Lawrence EJ, Karageorgos L, Belakhov V, Baasov T, Hopwood JJ, Brooks DA.

JIMD Rep. 2014;13:139-47. doi: 10.1007/8904_2013_270. Epub 2013 Nov 6.

6.

Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells.

Keating DJ, Winter MA, Hemsley KM, Mackenzie KD, Teo EH, Hopwood JJ, Brooks DA, Parkinson-Lawrence EJ.

Neuroscience. 2012 Dec 27;227:110-8. doi: 10.1016/j.neuroscience.2012.09.034. Epub 2012 Sep 25.

PMID:
23022219
7.

Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats.

Ponder KP, O'Malley TM, Wang P, O'Donnell PA, Traas AM, Knox VW, Aguirre GA, Ellinwood NM, Metcalf JA, Wang B, Parkinson-Lawrence EJ, Sleeper MM, Brooks DA, Hopwood JJ, Haskins ME.

Mol Ther. 2012 May;20(5):898-907. doi: 10.1038/mt.2012.9. Epub 2012 Mar 6.

8.

Lysosomal storage disease: revealing lysosomal function and physiology.

Parkinson-Lawrence EJ, Shandala T, Prodoehl M, Plew R, Borlace GN, Brooks DA.

Physiology (Bethesda). 2010 Apr;25(2):102-15. doi: 10.1152/physiol.00041.2009. Review.

9.

N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples.

Parkinson-Lawrence EJ, Muller VJ, Hopwood JJ, Brooks DA.

Clin Chim Acta. 2007 Feb;377(1-2):88-91. Epub 2006 Sep 1.

PMID:
17027703
10.

Common antigenicity for two glycosidases.

Kakavanos R, Lehn P, Callebaut I, Meikle PJ, Parkinson-Lawrence EJ, Hopwood JJ, Brooks DA.

FEBS Lett. 2006 Jan 9;580(1):87-92. Epub 2005 Dec 6.

11.

Immunochemical analysis of CD107a (LAMP-1).

Parkinson-Lawrence EJ, Dean CJ, Chang M, Hopwood JJ, Meikle PJ, Brooks DA.

Cell Immunol. 2005 Jul-Aug;236(1-2):161-6. Epub 2005 Sep 15.

PMID:
16168398

Supplemental Content

Loading ...
Support Center